PUBLISHER: 360iResearch | PRODUCT CODE: 1584701
PUBLISHER: 360iResearch | PRODUCT CODE: 1584701
Preterm Birth & PROM Testing Market by Type (Biochemical Markers, Ferning Test, Fetal Fibronectin), Sample (Amniotic Fluid, Blood, Urine), End-User - Global Forecast 2025-2030
The Preterm Birth & PROM Testing Market was valued at USD 1.55 billion in 2023, expected to reach USD 1.64 billion in 2024, and is projected to grow at a CAGR of 6.20%, to USD 2.36 billion by 2030.
Preterm birth and prelabor rupture of membranes (PROM) testing represent a crucial segment of maternal and fetal health diagnostics. These tests are designed to assess risks associated with early labor and amniotic sac rupture, allowing for timely intervention to prevent complications. The burgeoning necessity for these tests is driven by rising preterm birth rates and increased awareness of maternal health, necessitating advanced diagnostic solutions in hospitals, clinics, and maternal health centers. Key market applications include assessing the risk of preterm labor and monitoring high-risk pregnancies, largely driven by technological advancements such as biomarker-based tests and point-of-care testing devices. Furthermore, their end-use scope extends primarily to healthcare providers and diagnostics laboratories, serving as pivotal tools for obstetricians and gynecologists in prenatal care. In terms of market growth, factors such as the increasing prevalence of preterm births, greater healthcare spending, and innovative approaches like non-invasive testing are significant influencers. Latest opportunities lie in the development of cost-effective, highly accurate, and easily accessible testing kits, particularly in emerging markets. Companies can capitalize on these by investing in R&D and strategic partnerships to enhance market penetration and product accessibility. However, market growth faces limitations due to high device costs, regulatory hurdles, and limited awareness in low-income regions, posing significant challenges. Moreover, competitive pressures and dependency on healthcare policy frameworks could slow market expansion. Innovations focusing on AI-driven predictive analytics, integrated digital platforms for patient monitoring, and enhanced biomarker specificity may offer new avenues for growth. The complex nature of this market demands adaptive strategies, focusing on personalized medicine trends and patient-centric care approaches, to spur increased adoption and competitive advantage. Overall, businesses should emphasize enhancing existing technologies, entering untapped markets, and improving collaborative efforts with healthcare providers to sustain growth and drive innovation.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 1.55 billion |
| Estimated Year [2024] | USD 1.64 billion |
| Forecast Year [2030] | USD 2.36 billion |
| CAGR (%) | 6.20% |
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Preterm Birth & PROM Testing Market
The Preterm Birth & PROM Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Prevalence of preterm births owing to the increasing rates of diabetes and hypertension
- Rising focus on the development of point-of-care testing solutions
- Growing government and healthcare initiatives aimed at reducing preterm birth rates
- Market Restraints
- Rising concerns about false positive results of PROM tests
- Market Opportunities
- Rising investment by companies for the development of preterm birth & PROM testing solutions
- Emerging collaborative efforts in research and development activities for PROM tests
- Market Challenges
- Stringent regulations and varying approval processes for preterm birth & PROM tests
Porter's Five Forces: A Strategic Tool for Navigating the Preterm Birth & PROM Testing Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Preterm Birth & PROM Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Preterm Birth & PROM Testing Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Preterm Birth & PROM Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Preterm Birth & PROM Testing Market
A detailed market share analysis in the Preterm Birth & PROM Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Preterm Birth & PROM Testing Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Preterm Birth & PROM Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Preterm Birth & PROM Testing Market
A strategic analysis of the Preterm Birth & PROM Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Preterm Birth & PROM Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BillionToOne, Inc., Biosynex SA, Eurofins Scientific SE, F. Hoffmann-La Roche AG, FUJIFILM Holdings Corporation, GE HealthCare Technologies, Inc., Hologic, Inc., Igenomix India Private Limited, Illumina, Inc., Koninklijke Philips N.V., Laboratory Corporation of America Holdings, Medix Biochemica Group, Nanjing Liming Bio-products Co., Ltd., Natera, Inc., NX Prenatal, Inc., Pro Lab Diagnostics Inc, Qiagen N.V., Revvity, Inc., Samsung Electronics Co., Ltd., Sekisui Diagnostics, LLC, Sera prognostics, Inc., Siemens Healthineers AG, The Cooper Companies, Inc., and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
This research report categorizes the Preterm Birth & PROM Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Type, market is studied across Biochemical Markers, Ferning Test, Fetal Fibronectin, Nitazine Test, Pelvic exam, Pooling, Ultrasound, and Uterine Monitoring. The Biochemical Markers is further studied across Alpha-fetoprotein, C-Reactive Protein, Corticotropin-Releasing Hormone, IL-1, IL-2, IL-8, TNF-a, Insulin-like Growth Factor Binding Protein-1, Interleukin (IL)-6, and Placental Alpha Microglobulin-1.
- Based on Sample, market is studied across Amniotic Fluid, Blood, Urine, and Vaginal Secretions.
- Based on End-User, market is studied across Diagnostic Laboratories, Hospitals & Clinics, and Specialty Centers.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Prevalence of preterm births owing to the increasing rates of diabetes and hypertension
- 5.1.1.2. Rising focus on the development of point-of-care testing solutions
- 5.1.1.3. Growing government and healthcare initiatives aimed at reducing preterm birth rates
- 5.1.2. Restraints
- 5.1.2.1. Rising concerns about false positive results of PROM tests
- 5.1.3. Opportunities
- 5.1.3.1. Rising investment by companies for the development of preterm birth & PROM testing solutions
- 5.1.3.2. Emerging collaborative efforts in research and development activities for PROM tests
- 5.1.4. Challenges
- 5.1.4.1. Stringent regulations and varying approval processes for preterm birth & PROM tests
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.2.1. Type: Growing use of biochemical markers for early detection and management of preterm birth & PROM
- 5.2.2. Sample: Expanding the use of amniotic fluid testing in clinical settings owing to high specificity and sensitivity
- 5.2.3. End-User: Growing use of preterm birth & PROM tests in diagnostic laboratories owing to accuracy and mass testing
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Preterm Birth & PROM Testing Market, by Type
- 6.1. Introduction
- 6.2. Biochemical Markers
- 6.2.1. Alpha-fetoprotein
- 6.2.2. C-Reactive Protein
- 6.2.3. Corticotropin-Releasing Hormone
- 6.2.4. IL-1, IL-2, IL-8, TNF-a
- 6.2.5. Insulin-like Growth Factor Binding Protein-1
- 6.2.6. Interleukin (IL)-6
- 6.2.7. Placental Alpha Microglobulin-1
- 6.3. Ferning Test
- 6.4. Fetal Fibronectin
- 6.5. Nitazine Test
- 6.6. Pelvic exam
- 6.7. Pooling
- 6.8. Ultrasound
- 6.9. Uterine Monitoring
7. Preterm Birth & PROM Testing Market, by Sample
- 7.1. Introduction
- 7.2. Amniotic Fluid
- 7.3. Blood
- 7.4. Urine
- 7.5. Vaginal Secretions
8. Preterm Birth & PROM Testing Market, by End-User
- 8.1. Introduction
- 8.2. Diagnostic Laboratories
- 8.3. Hospitals & Clinics
- 8.4. Specialty Centers
9. Americas Preterm Birth & PROM Testing Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Preterm Birth & PROM Testing Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Preterm Birth & PROM Testing Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.3.1. Novocuff Inc. secures USD 26 million in Series A funding to advance pioneering device addressing preterm birth and PROM with global impact
- 12.3.2. Clarius Mobile Health's FDA-cleared Clarius OB AI tool enhances prenatal care with automated fetal biometry in the U.S. and Canada
- 12.3.3. Lumos Diagnostics secures an additional USD 5 million from Hologic to enhance preterm birth diagnostics with advanced fetal fibronectin test
- 12.3.4. Samsung Medison acquires Sonio SAS to integrate advanced AI technologies with ultrasound systems
- 12.3.5. Natera Inc. unveils revolutionary cell-free DNA RhD test improving RhD-negative pregnancy care and conserving RhIg resources
- 12.3.6. Revvity unveils NGS panel workflow to enhance newborn screening capabilities
- 12.3.7. BillionToOne launches a new non-invasive prenatal test for preterm birth risk and PROM testing
- 12.3.8. Cord Blood Registry (CBR) and Fulgent Genetics introduce advanced genetic testing services
- 12.3.9. Bloomlife and PeriGen collaborate to address maternal and fetal health needs in underserved regions
- 12.3.10. BillionToOne and Janssen collaborate on phase 3 AZALEA clinical trial of nipocalimab for HDFN
- 12.3.11. Hologic collaborates with AAGL and Inovus Medical to advance OB-GYN training with advanced simulation technology
- 12.3.12. GE HealthCare receives USD 44 million Gates Foundation grant to develop AI-assisted ultrasound for improving maternal and child healthcare in low-and-middle-income countries
- 12.4. Strategy Analysis & Recommendation
- 12.4.1. Hologic, Inc.
- 12.4.2. Laboratory Corporation of America Holdings
- 12.4.3. Revvity, Inc.
- 12.4.4. Siemens Healthineers AG
Companies Mentioned
- 1. Abbott Laboratories
- 2. BillionToOne, Inc.
- 3. Biosynex SA
- 4. Eurofins Scientific SE
- 5. F. Hoffmann-La Roche AG
- 6. FUJIFILM Holdings Corporation
- 7. GE HealthCare Technologies, Inc.
- 8. Hologic, Inc.
- 9. Igenomix India Private Limited
- 10. Illumina, Inc.
- 11. Koninklijke Philips N.V.
- 12. Laboratory Corporation of America Holdings
- 13. Medix Biochemica Group
- 14. Nanjing Liming Bio-products Co., Ltd.
- 15. Natera, Inc.
- 16. NX Prenatal, Inc.
- 17. Pro Lab Diagnostics Inc
- 18. Qiagen N.V.
- 19. Revvity, Inc.
- 20. Samsung Electronics Co., Ltd.
- 21. Sekisui Diagnostics, LLC
- 22. Sera prognostics, Inc.
- 23. Siemens Healthineers AG
- 24. The Cooper Companies, Inc.
- 25. Thermo Fisher Scientific Inc.
LIST OF FIGURES
- FIGURE 1. PRETERM BIRTH & PROM TESTING MARKET RESEARCH PROCESS
- FIGURE 2. PRETERM BIRTH & PROM TESTING MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 11. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. AMERICAS PRETERM BIRTH & PROM TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 13. AMERICAS PRETERM BIRTH & PROM TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. UNITED STATES PRETERM BIRTH & PROM TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 15. UNITED STATES PRETERM BIRTH & PROM TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. ASIA-PACIFIC PRETERM BIRTH & PROM TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. ASIA-PACIFIC PRETERM BIRTH & PROM TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 20. PRETERM BIRTH & PROM TESTING MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 21. PRETERM BIRTH & PROM TESTING MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. PRETERM BIRTH & PROM TESTING MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. PRETERM BIRTH & PROM TESTING MARKET DYNAMICS
- TABLE 7. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY ALPHA-FETOPROTEIN, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY C-REACTIVE PROTEIN, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY CORTICOTROPIN-RELEASING HORMONE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY IL-1, IL-2, IL-8, TNF-A, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-1, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY INTERLEUKIN (IL)-6, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY PLACENTAL ALPHA MICROGLOBULIN-1, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 17. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY FERNING TEST, BY REGION, 2018-2030 (USD MILLION)
- TABLE 18. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY FETAL FIBRONECTIN, BY REGION, 2018-2030 (USD MILLION)
- TABLE 19. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY NITAZINE TEST, BY REGION, 2018-2030 (USD MILLION)
- TABLE 20. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY PELVIC EXAM, BY REGION, 2018-2030 (USD MILLION)
- TABLE 21. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY POOLING, BY REGION, 2018-2030 (USD MILLION)
- TABLE 22. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
- TABLE 23. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY UTERINE MONITORING, BY REGION, 2018-2030 (USD MILLION)
- TABLE 24. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 25. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY AMNIOTIC FLUID, BY REGION, 2018-2030 (USD MILLION)
- TABLE 26. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
- TABLE 27. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 28. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY VAGINAL SECRETIONS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 29. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 30. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 31. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 32. GLOBAL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 33. AMERICAS PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 34. AMERICAS PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 35. AMERICAS PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 36. AMERICAS PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 37. AMERICAS PRETERM BIRTH & PROM TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 38. ARGENTINA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 39. ARGENTINA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 40. ARGENTINA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 41. ARGENTINA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 42. BRAZIL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 43. BRAZIL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 44. BRAZIL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 45. BRAZIL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 46. CANADA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 47. CANADA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 48. CANADA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 49. CANADA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 50. MEXICO PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 51. MEXICO PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 52. MEXICO PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 53. MEXICO PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 54. UNITED STATES PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 55. UNITED STATES PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 56. UNITED STATES PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 57. UNITED STATES PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 58. UNITED STATES PRETERM BIRTH & PROM TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 59. ASIA-PACIFIC PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 60. ASIA-PACIFIC PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 61. ASIA-PACIFIC PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 62. ASIA-PACIFIC PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 63. ASIA-PACIFIC PRETERM BIRTH & PROM TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 64. AUSTRALIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 65. AUSTRALIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 66. AUSTRALIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 67. AUSTRALIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 68. CHINA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 69. CHINA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 70. CHINA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 71. CHINA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 72. INDIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 73. INDIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 74. INDIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 75. INDIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 76. INDONESIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 77. INDONESIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 78. INDONESIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 79. INDONESIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 80. JAPAN PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 81. JAPAN PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 82. JAPAN PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 83. JAPAN PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 84. MALAYSIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 85. MALAYSIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 86. MALAYSIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 87. MALAYSIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 88. PHILIPPINES PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 89. PHILIPPINES PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 90. PHILIPPINES PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 91. PHILIPPINES PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 92. SINGAPORE PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 93. SINGAPORE PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 94. SINGAPORE PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 95. SINGAPORE PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 96. SOUTH KOREA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 97. SOUTH KOREA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 98. SOUTH KOREA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 99. SOUTH KOREA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 100. TAIWAN PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 101. TAIWAN PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 102. TAIWAN PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 103. TAIWAN PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 104. THAILAND PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 105. THAILAND PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 106. THAILAND PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 107. THAILAND PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 108. VIETNAM PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 109. VIETNAM PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 110. VIETNAM PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 111. VIETNAM PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 112. EUROPE, MIDDLE EAST & AFRICA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 113. EUROPE, MIDDLE EAST & AFRICA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 114. EUROPE, MIDDLE EAST & AFRICA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 115. EUROPE, MIDDLE EAST & AFRICA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 116. EUROPE, MIDDLE EAST & AFRICA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 117. DENMARK PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 118. DENMARK PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 119. DENMARK PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 120. DENMARK PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 121. EGYPT PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 122. EGYPT PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 123. EGYPT PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 124. EGYPT PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 125. FINLAND PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 126. FINLAND PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 127. FINLAND PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 128. FINLAND PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 129. FRANCE PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 130. FRANCE PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 131. FRANCE PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 132. FRANCE PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 133. GERMANY PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 134. GERMANY PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 135. GERMANY PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 136. GERMANY PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 137. ISRAEL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 138. ISRAEL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 139. ISRAEL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 140. ISRAEL PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 141. ITALY PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 142. ITALY PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 143. ITALY PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 144. ITALY PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 145. NETHERLANDS PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 146. NETHERLANDS PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 147. NETHERLANDS PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 148. NETHERLANDS PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 149. NIGERIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 150. NIGERIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 151. NIGERIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 152. NIGERIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 153. NORWAY PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 154. NORWAY PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 155. NORWAY PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 156. NORWAY PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 157. POLAND PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 158. POLAND PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 159. POLAND PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 160. POLAND PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 161. QATAR PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 162. QATAR PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 163. QATAR PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 164. QATAR PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 165. RUSSIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 166. RUSSIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 167. RUSSIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 168. RUSSIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 169. SAUDI ARABIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 170. SAUDI ARABIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 171. SAUDI ARABIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 172. SAUDI ARABIA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 173. SOUTH AFRICA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 174. SOUTH AFRICA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 175. SOUTH AFRICA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 176. SOUTH AFRICA PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 177. SPAIN PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 178. SPAIN PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 179. SPAIN PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 180. SPAIN PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 181. SWEDEN PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 182. SWEDEN PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 183. SWEDEN PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 184. SWEDEN PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 185. SWITZERLAND PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 186. SWITZERLAND PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 187. SWITZERLAND PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 188. SWITZERLAND PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 189. TURKEY PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 190. TURKEY PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 191. TURKEY PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 192. TURKEY PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 193. UNITED ARAB EMIRATES PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 194. UNITED ARAB EMIRATES PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 195. UNITED ARAB EMIRATES PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 196. UNITED ARAB EMIRATES PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 197. UNITED KINGDOM PRETERM BIRTH & PROM TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 198. UNITED KINGDOM PRETERM BIRTH & PROM TESTING MARKET SIZE, BY BIOCHEMICAL MARKERS, 2018-2030 (USD MILLION)
- TABLE 199. UNITED KINGDOM PRETERM BIRTH & PROM TESTING MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
- TABLE 200. UNITED KINGDOM PRETERM BIRTH & PROM TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 201. PRETERM BIRTH & PROM TESTING MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 202. PRETERM BIRTH & PROM TESTING MARKET, FPNV POSITIONING MATRIX, 2023
